JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266025

Human ADCK2 knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

ADCK2 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 1.

View Alternative Names

AARF, ADCK2_HUMAN, MGC20727, Putative ubiquinone biosynthesis protein AarF, Uncharacterized aarF domain-containing protein kinase 2, aarF domain containing kinase 2

1 Images
Sanger Sequencing - Human ADCK2 knockout HeLa cell line (AB266025)
  • Sanger seq

Unknown

Sanger Sequencing - Human ADCK2 knockout HeLa cell line (AB266025)

Homozygous : 1 bp deletion in exon 1.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp deletion in exon 1

Disease

Adenocarcinoma

Product details

Recommended control: Human wild-type HeLa cell line (ab255928). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266025-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266025 Human ADCK2 knockout HeLa cell line", "number":"AB266025-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266025-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266025 Human ADCK2 knockout HeLa cell line", "number":"AB266025-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
ADCK2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

ADCK2 also known as AarF Domain Containing Kinase 2 is a protein kinase with an approximate mass of 74 kDa. It displays expression mostly in mitochondrial compartments where it exhibits its mechanical role of transferring phosphates to substrate proteins. This kinase belongs to the ABC1 (Activity of bc1 complex) family of atypical kinases which are characterized by specific serine/threonine phosphorylation activities in various organisms.
Biological function summary

ADCK2 is involved in cellular energy production processes. It maintains a role in the mitochondrial function influencing synthesis and maintenance of the respiratory chain complexes. Although ADCK2 is not a part of the protein complexes directly it acts as a modifier that affects the efficiency of these complexes in energy metabolism. Researchers often focus on its impact within the mitochondrial dynamics realm which is important for cellular health and activity.

Pathways

ADCK2 holds a role in both coenzyme Q biosynthesis and oxidative phosphorylation pathways. Coenzyme Q biosynthesis pathway connects ADCK2 function with several Q biosynthesis proteins such as COQ6. In oxidative phosphorylation ADCK2 contributes indirectly by affecting the electron transport chain's efficiency where it indirectly interacts with proteins such as cytochrome c oxidase components playing roles in ATP production.

Altered ADCK2 expression has relations with mitochondrial myopathies and certain metabolic syndromes. These conditions often involve dysfunctions within the energy production process linking ADCK2 with proteins like COQ10 which are important in the respiratory chain. As such ADCK2 represents a potential target in understanding and addressing these metabolic imbalances and related clinical presentations.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com